NEW YORK (AP) — Drugmaker Pfizer says fourth-quarter profit plunged 59 percent because of restructuring and other charges and generic competition continuing to siphon off revenue from former blockbuster medicines.
Still, the world's second-biggest drugmaker topped Wall Street's modest expectations. Pfizer says net income was $2.57 billion, or 39 cents per share, down from $6.32 billion, or 85 cents per share, a year earlier.
Excluding one-time items, the maker of Viagra, arthritis drug Xeljanz and pneumonia vaccine Prevnar says net income would have been $3.69 billion, or 56 cents per share. That topped analyst expectations of 52 cents per share.
Revenue totaled $ 13.56 billion, down 2 percent. Analysts expected $13.36 billion.
The New York-based drugmaker forecast 2014 profit of $1.57 to $1.72 per share.
Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
If you use miles to get a free ticket on American Airlines, you may have to pay to check that suitcase.
The states on each side of the Ohio River are at opposite spectrums when it comes to how much your favorite pint of beer is taxed.
Shares in Italian eyewear maker Luxottica have risen sharply on the announcement that it will make frames for Google's new…
RadioShack plans to close up to 1,100 stores in the U.S. as its troubles continue to grow.
Target Corp says the massive data breach over the holidays helped push its profit down 46 percent.
Federal Reserve Chair Janet Yellen says that if the economy keeps improving, the Fed will take "further measured steps" to reduce…
The number of people applying for U.S. unemployment benefits declined 20,000 last week to 331,000, suggesting that Americans are facing fewer…
CVS Caremark is kicking the habit of selling tobacco products at its more than 7,600 drugstores nationwide.
Microsoft has named Satya Nadella, an executive in charge of the company's small, but growing business of delivering software and…
Financial markets steadied Tuesday after the turmoil of the previous day reverberated into the Asian session. However, lingering concerns…